Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas

Both tumor-associated neutrophils (TAN) and cancer-associated fibroblasts (CAFs) display specific phenotypic and functional features and contribute to tumor cell niche. However, their bidirectional crosstalk has been poorly studied, in particular in the context of hematological malignancies. Follicular lymphomas (FL) and diffuse large B-cell lymphomas (DLBCL) are two germinal center-derived lymphomas where various cell components of infiltrating microenvironment, including TAN and CAFs, have been demonstrated to favor directly and indirectly malignant B-cell survival, growth, and drug resistance. We show here that, besides a direct and contact-dependent supportive effect of neutrophils on DLBCL B-cell survival, mediated through the BAFF/APRIL pathway, neutrophils and stromal cells cooperate to sustain FL B-cell growth. This cooperation relies on an overexpression of IL-8 by lymphoma-infiltrating stromal cells that could thereafter efficiently promote neutrophil survival and prime them to neutrophil extracellular trap. Conversely, neutrophils are able to activate stromal cells in a NF-κB-dependent manner, inducing their commitment towards an inflammatory lymphoid stroma phenotype associated with an increased capacity to trigger malignant B-cell survival, and to recruit additional monocytes and neutrophils through the release of CCL2 and IL-8, respectively. Altogether, a better understanding of the lymphoma-supporting effects of neutrophils could be helpful to design new anti-tumor therapeutic strategies.

[1]  A. Maseri,et al.  Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps , 2014, Journal of thrombosis and haemostasis : JTH.

[2]  Burkhard Ludewig,et al.  B cell homeostasis and follicle confines are governed by fibroblastic reticular cells , 2014, Nature Immunology.

[3]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[4]  M. I. Crespo,et al.  Neutrophils Exhibit Differential Requirements for Homing Molecules in Their Lymphatic and Blood Trafficking into Draining Lymph Nodes , 2014, The Journal of Immunology.

[5]  R. Gascoyne,et al.  The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.

[6]  X. Yuan,et al.  The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression , 2014, Cell Death and Disease.

[7]  S. Pileri,et al.  Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma. , 2014, Blood.

[8]  K. Tarte,et al.  COX-2–Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis , 2014, Clinical Cancer Research.

[9]  T. K. van den Berg,et al.  Failure To Detect Functional Neutrophil B Helper Cells in the Human Spleen , 2014, PloS one.

[10]  S. Serrano,et al.  Correction: Corrigendum: B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen , 2014, Nature Immunology.

[11]  C. Klein,et al.  Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab. , 2013, Blood.

[12]  D. Jeoung,et al.  Human follicular dendritic cells promote germinal center B cell survival by providing prostaglandins. , 2013, Molecular immunology.

[13]  K. Tarte,et al.  Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells , 2012, Haematologica.

[14]  K. Tarte,et al.  Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis , 2012, Front. Immun..

[15]  Dong-hee Kim,et al.  Differential effect of CCL2 on constitutive neutrophil apoptosis between normal and asthmatic subjects , 2012, Journal of cellular physiology.

[16]  R. Mebius,et al.  Interdependence of stromal and immune cells for lymph node function. , 2012, Trends in immunology.

[17]  S. Lang,et al.  A novel p38‐MAPK signaling axis modulates neutrophil biology in head and neck cancer , 2012, Journal of leukocyte biology.

[18]  K. Tarte,et al.  Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. , 2011, Blood.

[19]  A. Challa,et al.  ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process , 2011, Annals of the rheumatic diseases.

[20]  A. Kater,et al.  Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. , 2011, Blood.

[21]  G. Pizzolo,et al.  Toll‐Like Receptor‐3‐Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils , 2011, Stem cells.

[22]  Xiao‐Yu Yin,et al.  Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. , 2011, Journal of hepatology.

[23]  A. Chevailler,et al.  CCR7 is involved in the migration of neutrophils to lymph nodes. , 2011, Blood.

[24]  F. Berrino,et al.  Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. , 2010, Blood.

[25]  T. Habermann,et al.  Predicting survival for diffuse large B‐cell lymphoma patients using baseline neutrophil/lymphocyte ratio , 2010, American journal of hematology.

[26]  Pierre Tattevin,et al.  Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. , 2010, The Journal of infectious diseases.

[27]  L. Pasqualucci,et al.  Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma , 2009, Nature.

[28]  J. Cerhan,et al.  A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. , 2009, Blood.

[29]  L. Staudt,et al.  Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.

[30]  F. Bazzoni,et al.  Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. , 2008, Immunology letters.

[31]  F. Montecucco,et al.  Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche , 2008, Stem cells.

[32]  W. Fridman,et al.  Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation , 2007, Journal of leukocyte biology.

[33]  K. Tarte,et al.  Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. , 2007, Blood.

[34]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[35]  T. Hara,et al.  Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes , 2004, The Journal of experimental medicine.

[36]  M. Czuczman,et al.  Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  J. Baars,et al.  Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy , 2003, Leukemia.

[38]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[39]  M. Colombo,et al.  Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma. , 2014, Cancer discovery.

[40]  K. Tarte,et al.  Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling , 2012, Leukemia.

[41]  J. Tao,et al.  Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis , 2009, Leukemia.

[42]  J. Tschopp,et al.  Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. , 2007, Blood.

[43]  Juan F. García,et al.  The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. , 2006, Haematologica.

[44]  L. Ivashkiv,et al.  IFN-gamma-primed macrophages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Stat1. , 2005, Journal of immunology.

[45]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.